Spontaneous Bacterial Peritonitis clinical trials

Explore recruiting spontaneous bacterial peritonitis clinical trials.

Recruiting spontaneous bacterial peritonitis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Spontaneous Bacterial Peritonitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis.

Belgium, Spain, France, Germany, Poland

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis

Netherlands, France, Norway, Hungary, Italy, Lithuania +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Czechia, Belgium, Spain, Hungary, Italy, Netherlands +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Norfloxacin for amelioration of portal hypertension in decompensated cirrhosis - a randomized, placebo-controlled, double-blinded clinical trial

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

Germany, Italy, France, Hungary, Greece, Czechia +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Denmark, Belgium, Spain, Netherlands, Germany, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Spontaneous Bacterial Peritonitis trials by city

Spontaneous Bacterial Peritonitis clinical trials

Recruiting spontaneous bacterial peritonitis studies right now

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Faecal Microbiota Transplantation for Liver Cirrhosis

Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis

Also recruiting in Europe

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis.

A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Norfloxacin for amelioration of portal hypertension in decompensated cirrhosis - a randomized, placebo-controlled, double-blinded clinical trial

AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Spontaneous Bacterial Peritonitis trials by city

Other conditions